DexCom is enhancing Stelo through AI-driven personalization, integration with devices like the Oura Ring and expanded distribution via Amazon, setting the stage for continued market penetration.
Combining Dexcom glucose data with the biometrics collected by Oura Ring will provide users of both products w SAN DIEGO, November 14, 2024--This World Diabetes Day, DexCom, Inc. (NASDAQ ...
Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...
My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Dexcom Inc. fourth quarter 2024 earnings release conference call. All lines ...
DexCom projects 2025 revenue of $4.6 billion, representing 14% growth. This forecast assumes strong demand for CGM systems, expanded reimbursement coverage, and a second-half launch of a 15-day G7 ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday ...
DexCom (NASDAQ:DXCM), known for its continuous glucose monitoring (CGM) systems, recently unveiled its Q4 2024 earnings report on Feb. 13, 2025. This release highlighted an 8% growth in revenue ...
DexCom Inc (DXCM) reports strong international growth and expanding customer base, while facing margin pressures and US market challenges. On today’s Asking for a Trend, host Josh Lipton and Yahoo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results